FDA ends Teva Plan B OTC dominance

Share this article:

Plan B is now going generic. NPR reports that the FDA did a 180 on its July 2012 marketing decision that allowed the emergency contraception to be sold over the counter without an age restriction.

The age-free availability came after legal wrangling that brought together the FDA, the Department of Justice, and the United States District Court for the Eastern District of New York.

Pro-limit parties, which included the Department of Justice and the White House, backed off, keeping it out of the Supreme Court. The détente came with a provision in which the FDA granted drugmaker Teva three years of generic protection. NPR reports that the regulator has changed its mind as long as generic labels note that the drug is meant for women 17 or older.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.